Literature DB >> 19007813

Rapid, semi-automated, and inexpensive radioimmunoassay of cAMP: application in GPCR-mediated adenylate cyclase assays.

Justin T Brown1, Andrew Kant, Richard B Mailman.   

Abstract

Cyclic AMP (cAMP) is an important signal transduction second messenger that is commonly used as a functional mirror on the actions of G protein-coupled receptors that can activate or inhibit adenylate cyclases. A radioimmunoassay for cAMP with femtomole sensitivity was first reported by Steiner more than 30 years ago, and there have been several subsequent modifications that have improved this assay in various ways. Here we describe additional improvement to existing methods that markedly improve speed and reduce cost without sacrificing sensitivity, and is also adaptable to analysis of cGMP. The primary antibody is coupled directly to magnetic beads that are then separated from unbound marker using filtration on microplates. This eliminates the need for a secondary antibody, and markedly increases throughput. In addition, we report a simple, reproducible, and inexpensive method to make the radiomarker used for this assay. Although still requiring the use of radioactivity, the resulting method retains a high degree of accuracy and precision, and is suitable for low-cost high throughput screening. Use of aspects of this method can also improve throughput in other radioimmunoassays.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007813      PMCID: PMC2717699          DOI: 10.1016/j.jneumeth.2008.10.016

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  16 in total

Review 1.  Adenylate cyclase assay.

Authors:  Y Salomon
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

2.  Gammaflow: a completely automated radioimmunoassay system.

Authors:  G Brooker; W L Terasaki; M G Price
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

3.  Saturation assay for cyclic AMP using endogenous binding protein.

Authors:  B L Brown; R P Ekins; J D Albano
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

4.  Radioimmunoassay for the measurement of cyclic nucleotides.

Authors:  A L Steiner; R E Wehmann; C W Parker; D M Kipnis
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

5.  Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence.

Authors:  E F Ullman; H Kirakossian; S Singh; Z P Wu; B R Irvin; J S Pease; A C Switchenko; J D Irvine; A Dafforn; C N Skold
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 6.  Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's disease.

Authors:  I McPhee; L C D Gibson; J Kewney; C Darroch; P A Stevens; D Spinks; A Cooreman; S J MacKenzie
Journal:  Biochem Soc Trans       Date:  2005-12       Impact factor: 5.407

7.  RIA determination and immunofluorescence localization of cyclic nucleotides in rainbow trout (Salmo gairdneri) testes.

Authors:  R Schulz; V Blüm
Journal:  Gen Comp Endocrinol       Date:  1985-02       Impact factor: 2.822

8.  A rapid and economical method of preparing radioiodinated cyclic nucleotide derivatives for use in radioimmunoassays.

Authors:  W F Oehlenschlager; S W Kubalak; M G Currie
Journal:  J Immunoassay       Date:  1990

9.  trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.

Authors:  W K Brewster; D E Nichols; R M Riggs; D M Mottola; T W Lovenberg; M H Lewis; R B Mailman
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

View more
  4 in total

1.  Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations.

Authors:  J Corey Fowler; Supriyo Bhattacharya; Jonathan D Urban; Nagarajan Vaidehi; Richard B Mailman
Journal:  Mol Pharmacol       Date:  2012-03-13       Impact factor: 4.436

2.  SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C.

Authors:  Sang-Min Lee; Andrew Kant; Daniel Blake; Vishakantha Murthy; Kevin Boyd; Steven J Wyrick; Richard B Mailman
Journal:  Neuropharmacology       Date:  2014-06-12       Impact factor: 5.250

3.  Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor.

Authors:  Ilaria Cicalini; Barbara De Filippis; Nicola Gambacorta; Antonio Di Michele; Silvia Valentinuzzi; Alessandra Ammazzalorso; Alice Della Valle; Rosa Amoroso; Orazio Nicolotti; Piero Del Boccio; Letizia Giampietro
Journal:  Molecules       Date:  2020-04-15       Impact factor: 4.411

4.  Establishing a sensitive fluorescence-based quantification method for cyclic nucleotides.

Authors:  Nadine Gruteser; Viktoria Kohlhas; Sabine Balfanz; Arne Franzen; Anne Günther; Andreas Offenhäusser; Frank Müller; Viacheslav Nikolaev; Martin J Lohse; Arnd Baumann
Journal:  BMC Biotechnol       Date:  2020-08-27       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.